|New from NCI|
|Video--Statistics on Rare Cancer|
| ||What is a rare cancer? This video explains why more than 500 cancers are considered "rare" as well as their incidence and survival trends.|
|Promoting Exercise in Young Cancer Survivors|
| ||Results from a pilot study suggest that an interactive website may encourage young people who have finished cancer treatment to exercise regularly. Find out more about the next phase of this research.|
|Analysis of Lung Cancer Screening|
Who is most likely to benefit from lung cancer screening? A recent analysis led by the Veterans Health Administration seeks to answer this complicated question.
|Oral Contraceptives and Cancer Risk|
Birth control pills are linked to increased risk for some cancers and reduced risk for others. Read this updated fact sheet that summarizes the research on the relationship between the use of birth control pills and cancer.
|New Approval for Advanced Kidney Cancer|
| ||Approval for the targeted therapy cabozantinib (Cabometyx) has been expanded to include newly diagnosed patients with advanced renal cell carcinoma.|
|Delaying Metastases and Prolonging Survival in Prostate Cancer|
The Food and Drug Administration (FDA) has approved apalutamide (Erleada) for men with prostate cancer that has not spread. Learn about the trial that led to this approval.
|PDQ Summary Updates|
|Bile Duct Cancer Treatment|
We’ve revised our PDQ summary on treatment for bile duct cancer (cholangiocarcinoma) with updated descriptions and new illustrations of the different stages.
|Renal Cell (Kidney) Cancer Treatment|
We’ve updated our PDQ summary on treatment for renal cell cancer to include the latest tests used to diagnose and stage the disease as well as updated descriptions and illustrations of the different stages.
|Drug Information Updates|
|Abemaciclib Use in Breast Cancer|
We’ve updated our drug information summary for abemaciclib (Verzenio) to include a recent approval from FDA. Abemaciclib is now approved, in combination with aromatase inhibitors, as first-line therapy in postmenopausal women who have certain types of breast cancer.
|Durvalumab for Lung Cancer|
We’ve added a new indication to our drug information summary for durvalumab (Imfinzi). It was recently approved by FDA to treat certain types of lung cancer that cannot be removed by surgery.
No hay comentarios:
Publicar un comentario